Showing results (191-200 of 205) with videos related to
Sort By:
Pageof 21
Nature|September 4, 2009
Response and resistance to MEK inhibition in leukaemias initiated by hyperactive RasJennifer O Lauchle, Doris Kim, Doan T Le, et al.Cell|February 21, 2017
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in CancerMichael R Burgess, Eugene Hwang, Rana Mroue, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMichael W Deininger, Neil P Shah, Jessica K Altman, et al.Leukemia|February 19, 2020
Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemiaAnica M Wandler, Benjamin J Huang, Jeffrey W Craig, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2019
Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1Smita Bhatia, Yanjun Chen, F Lennie Wong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2013
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trialNitin Jain, Emily Curran, Neil M Iyengar, et al.Cell Genomics|January 23, 2026
Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseasesAlok Jaiswal, Tristan Kooistra, Vladislav Pokatayev, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in OncologyJerald P Radich, Michael Deininger, Camille N Abboud, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2016
NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017Arnel Pallera, Jessica K Altman, Ellin Berman, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 23, 2024
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyNeil P Shah, Ravi Bhatia, Jessica K Altman, et al.Pageof 21